探讨空间分割放疗在肿瘤治疗中的功效和毒性。
适应症：Radiotherapy-Induced Immune Priming
入组条件
纳入标准
- Patients with a bulky solid tumor with a maximum diameter \>4 cm or a refractory solid tumor.
排除标准
- Tumors involving hollow viscera that are considered to have a clinically significant risk of bleeding or perforation.
- Patients with impaired consciousness or who are unable to care for themselves.
入组条件维持 ClinicalTrials.gov 原始英文登记资料，实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源：ClinicalTrials.gov，每两周自动更新，最后同步：2026年10月8日。